NCT00257387View on ClinicalTrials.gov

Study Evaluating Cyclosporine Dose Reduction and Cyclosporine Elimination in Chinese Kidney Transplants

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 30, 2004

Study Completion Date

August 31, 2006

Conditions
Kidney Transplant
Interventions
DRUG

Cyclosporine

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00257387 - Study Evaluating Cyclosporine Dose Reduction and Cyclosporine Elimination in Chinese Kidney Transplants | Biotech Hunter | Biotech Hunter